论文部分内容阅读
多环节对抗缺血性脑损伤──达纳康本刊讯法国博福－益普生制药集团研制生产的达纳康（ｔａｎａｋａｎ）以全面的药理特性和理想的安全性及耐受性，多环节对抗缺血性脑损伤，树立了缺血性脑血管病治疗的新观念。其主要药理特性为：（１）改善缺血组织的血循环，增加血流量...
Multi-part fight against ischemic brain damage ─ ─ Dana Kang Benfo France Bofu - Ipsen Pharmaceutical Group developed and manufactured tanakan (tanakan) with comprehensive pharmacological properties and the ideal safety and tolerability, and more Links against ischemic brain injury, establish a new concept of treatment of ischemic cerebrovascular disease. Its main pharmacological properties are: (1) to improve the blood circulation of ischemic tissue and increase blood flow ...